PathoNostics was founded in 2011 in Maastricht, The Netherlands and became an important player in the fungal diagnostic field. PathoNostics offers a range of diagnostic real-time PCR kits for the detection of fungal infections. The company currently have five products on the market: AsperGenius®, DermaGenius®, PneumoGenius®, MucorGenius® and CandidaGenius®.
At PathoNostics, the objective is to rapidly detect the disease-causing fungus and simultaneously identify antifungal resistance, allowing clinicians to initiate a dedicated and timely therapy and save on costs and lives. By using these real-time PCR kits, incorrect or unnecessary medical treatment, side effects, and costs can be avoided. The early diagnosis of fungal infections can greatly improve the clinical success and infection control.